chrisvoncsefalvay/vaers-outcomes huggingface dataset:
suddenly my vision in the left eye got blurry and I lost half of my visual field/was diagnosed with retinal detachment; This is a spontaneous report from a contactable consumer (patient). A 45-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration, administered in Arm Left on 24Mar2021 08:30 (Batch/Lot Number: ER8730) at the age of 45-years-old as SINGLE DOSE for covid-19 immunisation. The COVID-19 vaccine was administered at Pharmacy or Drug Store. Medical history was none. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient's concomitant medications were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Patient was not pregnant. On 13Apr2021 09:00 AM, suddenly her vision in the left eye got blurry and she lost half of her visual field. She was diagnosed with retinal detachment and had a surgery. She did not have any of the risk factors such as diabetes or hypertension. There's no other explanation for it and this condition has not been in her family history at all. No injuries, no accidents or any other cause. She suspected it could be a side effect given that this condition has been reported in autoimmune disorders (could be related to triggering the immune system), and/ or given that retinal detachment has been reported in Covid-19 as a rare symptom. She heard of three other cases of retinal detachment in her community, in the past couple of months. Given that it's a rare condition, coinciding with taking Pfizer vaccination was suspicious or at least worth some accurate research. Event result in Doctor or other healthcare professional office/clinic visit and Emergency room/department or urgent care. The patient was hospitalized for 1 days and it is also resulted in disability. The patient underwent lab tests and procedures which included covid-19 virus test (Nasal Swab): negative   on 14Apr202. Therapeutic measures were taken as a result of retinal detachment included Surgery. The outcome of the event was Recovered/Resolved with Sequel. Since the vaccination, the patient was not been tested for COVID-19.
The patient received 0.25mL of the Moderna bivalent vaccine instead of 0.5mL on 9/6/2022. The patient came back on 9/7/2022 to receive the second 0.25mL.
2 hours after receiving his first vaccine the patient was presenting with light headedness, sweaty, pale, and stomach pain. I took his BP and it was 80/60 with a pulse of 60. I called 911 because he had a history of CHF and I didn't want his pulse to drop and not have other trained personnel on hand if CPR was required. I gave him water to try to raise his BP and rechecked his BP after 5 minutes and it raised to 127/83 with a pulse of 64. He stopped sweating and his color came back in his face at that time. The EMT's rechecked vitals and ended up taking him to the ED to run tests.
Diarrhea; Nausea; Vomiting; fever of 100.4 F; Arm sore; A spontaneous report was received from a 60-year-old, female nurse who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced arm sore, diarrhea, nausea, vomiting and fever of 100.4 F.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 02 Jan 2021 at noon, prior to the onset of the events, the patient received her first of two planned doses of mRNA-1273 (Lot number: Unknown) intramuscularly in the right deltoid for prophylaxis of COVID-19 infection.  However, on 02 Jan 2021, after receiving the vaccine, later the patient had an arm sore for 24 hours.    On 04 Jan 2021, she had nausea, vomiting, fever (100.4F) and diarrhea.   Treatment for the events was acetaminophen.  Action taken with mRNA-1273 in response to the event was not reported.  The outcome for the event, arm sore was resolved. The outcome for the events nausea, vomiting, fever of 100.4 F and diarrhea was unknown.; Reporter's Comments: This case concerns a 60-year-old, female, who experienced non-serious event of diarrhea, pain in extremity, nausea, vomiting and pyrexia. Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
PATIENT REPORTED DIZZINESS, NAUSEA, TONGUE/THROAT SWELLING SENSATION, FLUSHING, CHEST PRESSURE, CHEST PAIN. ANAPHYLAXIS. CALLED 911 . ADMINISTERED EPIPEN INJECTION. TRANSPORTED TO HOSPITAL BY PARAMEDIC.
02/26/07 @ 0900 EE C/O FEVER, WEAKNESS, SWELLING OF PAROTID GLANDS, AND FINE RASH ON CHEST, HEAD AND UPPER ARMS X 4 DAYS. EE STATES THAT S/S STARTED 02/23/07 WHEN HE WAS AT DFW AIRPORT. EE RECEIVED MMR VACCINE ON 2-13-07. EE STATES THAT HE STILL FEELS WEAK, ``BUT I`M GETTING BETTER.`` TEMP: 98.3F. EE SENT TO CONCENTRA CLINIC FOR FURTHER EVALUATION OF VACCINE REACTION VS. OTHER ILLNESS. 1200- EE RETURNS WITH DOCUMENTATION FROM DR. INDICATING THAT HE requires no treatment.
Received vaccine 10/7/04: on 10/14 : my right arm from deltoid to elbow was swollen and discolored. Wife received shot on 10/14 and told the nurse about my swollen arm and discoloration on my deltoid became enlarged and swollen. Nurse told to go to ER. Also elbow to wrist was swollen.
moderate severe chills,(main symptom),,during bedtime,,,general body ache,,,unable to perform daily activity for 24 hrs,,,symptoms subsided rapidly after 24 hrs,,,also be noted ,alcohol was consumed 3 hrs after vac,,,2 beer,,,2 shot of vodka,,,ate normal dinner at 8pm.
Patient started vomiting after administration of first dose of Pfizer. First dose was administered at 15:16 and patient felt dizzy, c/o of headache and started vomiting right afterwards. Charge RN, ANM, and onsite provider was notified. Moved patient to triage area and her VS were as follow: BP: 96/50; HR: 73, SPO2: 98%. Patient was given a peppermint gum to chew and water. Patient felt better five minutes later. Patient stable, and released into the observation area for 30 minutes. Patient was accompanied by father d/c to home stable steady gait. Pt advised to seek emergency services for any further sx.
This spontaneous report as received from a physician and from a support services director refers to a patient of unknown age and gender. No information regarding the patient's medical history or concurrent conditions was provided. On 04-NOV-2015, the patient was vaccinated with an improperly stored dose of PNEUMOVAX 23 (lot# L013428, expiry date 03-FEB-2017; dose and route of administration were not reported). There were no concomitant therapies reported. The dose of the vaccine was exposed to temperature excursion (date unspecified): lasting for 136 hours, with the lowest recorded temperature of 31 degrees Fahrenheit (-1.11 degrees Celsius). No adverse effects were reported. There was no product quality complaint involved. This is one of several reports received from the same reporter. Additional information has been requested.
Right after Flu shot, felt very fatigued which got worse throughout the day- developed fever and internal pain all over body- had difficulty breathing and experienced pain in lungs, very weak/no energy and fast heart rate. A few days later, broke out with rash all over arms and spreading to neck area.
Missed work; Sickness; Slight fever; Achiness/pain; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of IMPAIRED QUALITY OF LIFE (Missed work), ILLNESS (Sickness), PYREXIA (Slight fever) and MYALGIA (Achiness/pain) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced IMPAIRED QUALITY OF LIFE (Missed work), ILLNESS (Sickness), PYREXIA (Slight fever) and MYALGIA (Achiness/pain). At the time of the report, IMPAIRED QUALITY OF LIFE (Missed work), ILLNESS (Sickness), PYREXIA (Slight fever) and MYALGIA (Achiness/pain) outcome was unknown.            Treatment and concomitant medications were not provided by reporter.
CHEST PAIN, SHORTNESS OF BREATH, DIZZINESS, CONSTITUTIONAL SYMPTOMS PROGRESSIVE WITH EACH ADMINISTRATION
This was my first booster shot. Within 12 hours, my fibromyalgia pain and weakness became more pronounced. My fatigue became worse. One week later, I'm still experiencing these adverse effects. I had these same problems after my initial 2 vaccines.
24 hrs later - eyes slightly swollen and had headache for a few hours. Presented to H.D 12/18/09
Mother says child cried non stop for 2 hours. Mother says child complained of pain in his legs, mother claimed trembling legs and that legs could not hold body up. Mother claims pain reliever was given and did not alleviate the pain. Doctor was not yet contacted at time of VAERS report.
administration /of the Twinrix vaccine  to a /17 year old patient.; This case was reported by a other health professional via call center representative and described the occurrence of inappropriate age at vaccine administration in a 17-year-old female patient who received HAB (Twinrix) (batch number A955S, expiry date 22nd May 2022) for prophylaxis.   Co-suspect products included hepatitis A and hepatitis B vaccine pre-filled syringe device (Twinrix Pre-Filled Syringe Device) injection syringe for prophylaxis.   On 17th May 2021, the patient received Twinrix and Twinrix Pre-Filled Syringe Device. On 17th May 2021, unknown after receiving Twinrix and Twinrix Pre-Filled Syringe Device, the patient experienced inappropriate age at vaccine administration. On an unknown date, the outcome of the inappropriate age at vaccine administration was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.  Additional case details were reported as follows: The 17 year old female patient was administered the Twinrix vaccine, which led to inappropriate age at vaccine administration.   No further events were reported. The reporter consented to follow up.
This spontaneous report as received from a registered nurse referring to an unspecified number of patients of unknown age and gender. The patients' medical history, concurrent conditions and concomitant therapy were not provided. On an unknown date, the patients were administered improperly stored doses of ROTATEQ oral liquid (orally) for prophylaxis. (Strength, dose number, lot number and expiration date were not provided). No adverse effects were reported. This is one of several reports from the same source. Additional information has been requested. Sender's Comments: US-009507513-1612USA013215: US-009507513-1612USA013214.
This case was reported by a consumer via call center representative and described the occurrence of shoulder pain in a adult male patient who received BOOSTRIX for prophylaxis. On an unknown date, the patient received BOOSTRIX. In December 2018, less than a year after receiving BOOSTRIX, the patient experienced shoulder pain and difficulty sleeping. On 11th January 2019, the outcome of the shoulder pain was recovered/resolved. On an unknown date, the outcome of the difficulty sleeping was unknown. It was unknown if the reporter considered the shoulder pain and difficulty sleeping to be related to BOOSTRIX. Additional details were provided as follows: The age at vaccination was not reported. After receiving BOOSTRIX, the patient experienced excruciating pain in his shoulder for 27 days. The patient was unable to sleep at night. The patient did not provide any further information.
Patient reported stomach ache, bad headache, nausea, fatigue, arm red/swollen, body aches, shivering
Vaccine administered in Employee Health Office to (L) deltoid - Returned to work in Emergency Department - Developed rash, dizziness, wheezing, SOB, Tx'd with EPINEPHRINE & ZANTAC.
The vaccine was given on Monday.  Tuesday afternoon he developed weakness in both legs and could not stand up.  This was a new development;  he had neuropathy in one leg but he had been able to stand up and walk three hours before.  He was helped to the bathroom.  He said he felt better and might want to stand up again.  He was helped to bed.  He was found dead around 5:30 Wednesday morning.    He was 94 years old and had a lot of medical conditions.  No one has indicated his death had anything to do with the vaccine.  I'm sure it's just a coincidence that he died so soon after receiving the vaccine
Muscle pain; Joint pain; Sore throat; Feeling unwell; stated she feels very weak; stated she had initially had a fever of 102 degrees Fahrenheit, and now has a fever of 100 degrees Fahrenheit; Chills; injection site soreness; Headache; This is a spontaneous report from a contactable consumer. A 60-year-old female patient received the first dose of bnt162b2 (BNT162B2, lot number: EK5730), via an unspecified route of administration on 17Dec2020 09:30 on the right upper shoulder at single dose for immunization. Medical history included stomach cancer over 20 years ago, clarifying she no longer has stomach cancer. The patient's concomitant medications were not reported. On 17Dec2020, the patient experienced injection site soreness, headache, chills, she initially had a fever of 102 degrees Fahrenheit and now has a fever of 100 degrees Fahrenheit. Yesterday evening (17Dec2020) she developed a fever with chills, saying she couldn't get warm, so she went to bed. She said when she got up this morning (18Dec2020), she had the other side effects: muscle pain, chills, joint pain, sore throat, feeling unwell, and she feels very weak. Reported she couldn't function when she woke up this morning. For the treatment of headache, the patient took 1 Ibuprofen 600mg tablet. She said she still has a headache, but her headache has improved. She said she took an over-the-counter Tylenol 500mg tablet. She received the COVID-19 shot at the hospital she is employed. The reported events did not require a visit to Emergency Room and Physician Office. The events headache, muscle pain, chills, joint pain, fever, sore throat was recovering, and the outcome of the remaining events was not recovered.
Information has been received from a physician concerning a 15 month old female who on 18-JUN-2007 was vaccinated subcutaneously in the left quadricep with a 0.5 mL dose of varicella virus vaccine live (Oka/Merck) (lot# 657412/0594U). Other vaccinations given on the same day included diphtheria toxoid (+) pertussis acellular vaccine (unspecified) (+) tetanus toxoid and pneumococcal 4 6B 9V 14 18C 19F 23F conj vaccine (CRM197) (PREVNAR). On 27-JUN-2007 (as reported by her mother) the patient developed a pimple like diaper rash. The physician reported the AE as "multiple red lesions in diaper area in different stages. Some scabbed over and other appeared to have fluids." The patient recovered. Follow-up information from a health professional indicated that on 29-JUN-2007 the patient developed red papules with fluid and crusting lesions on her diaper area. It was reported to be atypical chickenpox. The records of testing prior to release of the lot in question has been rechecked and found to be satisfactory. The lot met the requirements of the Center for Biologics Evaluation and Research and was released. Additional information has been requested.
Large bruise at injection site. On the next day (11-3) pt. experienced large hives and lips swelled - went to ER for treatment.
This spontaneous report as received from a physician refers to a 70 year old female patient with penicillin allergy and chronic obstructive pulmonary disease (COPD). The patient's medical history included coronary artery bypass in May 2014. On 25-JUN-2014 the patient was vaccinated with PNEUMOVAX 23 lot # J004080, expiration date 22-AUG-2014, 0.5 ml, intramuscular in the left deltoid (dose number was not reported). Concomitant therapies included SPIRIVA, ADVAIR, PLAVIX, ZOCOR, verapamil, LASIX, metoprolol, lisinopril (manufacturer unknown) and potassium supplements (unspecified). After receiving the vaccine, on approximately 25-JUN-2014, the patient experienced arm being tender, with redness, swelling and induration at the injection site. The patient went to emergency room and was hospitalized on 27-JUN-2014 to 01-JUL-2014 with cellulitis. During hospital stay, the patient experienced temperature of 102.9F and white blood cell count was 25100 (units not reported). The treatment given to the patient included vancomycin and LEVAQUIN. The outcome of cellulitis was reported as recovering/resolving (also reported as patient experienced clinical improvement over 48 hours). The relationship between PNEUMOVAX 23 and the event was not reported. Physician requested lot check on PNEUMOVAX 23 lot # J004080, expiration date 22-AUG-2014. Additional information has been requested.
Arm is painful; Eyes are swollen; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm is painful) and EYE SWELLING (Eyes are swollen) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On 25-Feb-2021, the patient experienced PAIN IN EXTREMITY (Arm is painful) and EYE SWELLING (Eyes are swollen). At the time of the report, PAIN IN EXTREMITY (Arm is painful) and EYE SWELLING (Eyes are swollen) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       Treatment information was not provided Concomitant information was not provided.   Reporter did not allow further contact
Provider diagnosed as Fasciculation bilaterally. Twitching in knees both bent and at rest. Pt requested and given Neurology referral based on sibling history of ALS. No medications given and asked to monitor and follow up if worsened.
Pt. c/o hives and swelling of entire right arm developing later the same day of her 2nd Moderna vaccine.  By 5/5, she had wheezing, coughing, itchy throat and eyes, and redness of face.  As of 5/7, she is still wheezing and has a bruise at the injection site.  Was seen at an urgent care center and advised to take Benadryl.  It is minimally helpful and wears off quickly and the symptoms return.  Pt. is currently uninsured and was given information for low-cost clinics.  She was advised to have wheezing evaluated.
Pt received immunizations on 5/22/12. MMR, Varicella and Hep A. Pt developed a fever on 5/24/12 with a tmax of 103 rectally. Rash developed later that day. Has a vesicular rash scattered on trunk, face and extremities. Pt has been fussy, decreased oral intake, slight soft stools, no longer sleeping through the night. Twin sister has similar sx which started first.
Systemic: Allergic: Itch (specify: facial area, extremeties)-Mild, Systemic: Allergic: Rash (specify: facial area, extremeties)-Mild
Severe itching in her face; Severe burning rash in her face; Pain in the face; Couldn't sleep the entire night; Severe burning rash in her face; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Severe itching in her face), BURNING SENSATION (Severe burning rash in her face), FACIAL PAIN (Pain in the face), INSOMNIA (Couldn't sleep the entire night) and RASH (Severe burning rash in her face) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012A20A) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In March 2021, the patient experienced PRURITUS (Severe itching in her face), BURNING SENSATION (Severe burning rash in her face), FACIAL PAIN (Pain in the face) and INSOMNIA (Couldn't sleep the entire night). March 2021, the patient experienced RASH (Severe burning rash in her face). The patient was treated with CORTISONE for Adverse event, at an unspecified dose and frequency and DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Adverse event, at an unspecified dose and frequency. At the time of the report, PRURITUS (Severe itching in her face), BURNING SENSATION (Severe burning rash in her face), FACIAL PAIN (Pain in the face), INSOMNIA (Couldn't sleep the entire night) and RASH (Severe burning rash in her face) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Staphylococcus test: negative (Negative) Culture done because they thought it was staph, but the result came back as not bacterial infected.     mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       Concomitant medication list was not provided.   This case was linked to MOD-2021-294462 (Patient Link).
The patient described redness (three inches), swelling, white spot on arm where the injection was given; The patient described redness (three inches), swelling, white spot on arm where the injection was given; The patient described redness (three inches), swelling, white spot on arm where the injection was given; This is a spontaneous case from initially reported by nurse to agency (reference number: SEQ19-05986) on 31-Oct-2019, concerning a 70-year-old female patient.  The patient's medical history included chronic obstructive pulmonary disease, high blood pressure, high cholesterol and allergies to doxycycline, penicillin, Zithromax (azithromycin) and bee stings. The patient's concomitant medication included lisinopril, omeprazole, amlodipine, Aspirin (acetylsalicylic acid), calcium, loratadine and Albuterol (salbutamol), all used for unknown indications.  On 29-Oct-2019, the patient was administered Afluria Quadrivalent [influenza vaccine; dose: 0.5 ml, route of administration: intramuscular, anatomical location: left arm; batch number: P100110966; expiration date: 27-May-2020] for influenza prophylaxis.   On 30-Oct-2019, one day after vaccination, the patient developed redness (three inches), swelling, white spot on arm, where the injection was given.   On 31-Oct-2019, the patient was treated with Benadryl (diphenhydramine) once every day at bedtime and prednisone, twice a day, for three days.  At the time of initial reporting, the outcome of the events was not resolved.   The case was assessed as non-serious. The reporter did not provide causality assessment.  Follow-up received from nurse via agency (reference number: SEQ19-06740) on 18-Nov-2019: Start date for treatment medications was provided. The narrative was amendment accordingly.   Company comment:The patient developed vaccination site discolouration, vaccination site swelling and vaccination site erythema one day after Afluria Quadrivalent was administered. Chronology is plausible. Based on currently provided information, causality for all events is assessed as possibly related.; Sender's Comments: The patient developed vaccination site discolouration, vaccination site swelling and vaccination site erythema one day after Afluria Quadrivalent was administered. Chronology is plausible. Based on currently provided information, causality for all events is assessed as possibly related.
3/6/2023 I woke up with a scratchy throat and sneezing. I felt it was maybe allergies. No other symptoms. The next day, the same thing. On 3/8/23 I woke up congested, runny nose and a tickle, not a bad cough. I was more tired than normal. I took an at home COVID test which was positive. I had a telehealth visit that day and was prescribed PAXLOVID after having bloodwork. On 3/9/23 I began taking PAXLOVID. By that time, I had a bad runny nose, sneezing a lot, the cough was worse and I was really tired. By 3/10/23 I noticed an improvement in the symptoms. I took the PAXLOVID for 5 days and my symptoms never progressed into anything worse.